Ostatní
Návod 
Charles River Laboratories International, Inc.
CRL
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
8.3B
Obrat
4B
Zisk
0B
Aktiva
8B
Dluh
3B
ROE
0%
ROA
0%
PE
-52
PS
2
Cena 1R
92-229
⌀ Cena
161.36
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
18-02-2026
Poslední dividenda
Profil
Charles River Laboratories International, Inc., neklinická smluvní výzkumná organizace, poskytuje služby v oblasti vyhledávání léčiv, neklinického vývoje a testování bezpečnosti ve Spojených státech, Evropě, Kanadě, Asii a Tichomoří a v mezinárodním měřítku. Působí ve třech segmentech: výzkumné modely a služby (RMS), zjišťování a posuzování bezpečnosti (DSA) a výrobní řešení (výroba). Segment RMS produkuje a prodává kmeny modelů výzkumu hlodavců a účelově chované krysy a myši pro použití výzkumníky. Tento segment také poskytuje řadu služeb, které pomáhají svým klientům při podpoře využívání výzkumných modelů ve výzkumu a screeningu neklinických lékových kandidátů, včetně výzkumných modelů, geneticky upravených modelů a služeb, řešení pro insourcing a výzkumných diagnostických služeb pro zvířata. Segment DSA nabízí služby včasného a in vivo objevování pro identifikaci a validaci nových cílů, chemických sloučenin a protilátek prostřednictvím dodání neklinických léků a léčebných kandidátů připravených pro posouzení bezpečnosti a služby posuzování bezpečnosti, jako je toxikologie, patologie, farmakologie bezpečnosti, bioanalýza, metabolismus léků a farmakokinetické služby. Výrobní segment poskytuje metody in vitro pro konvenční a rychlé testování kontroly kvality sterilních a nesterilních léčiv a spotřebních výrobků. Tento segment také nabízí specializované testování biologie, kterou zajišťují farmaceutické a biotechnologické společnosti, a ptačí vakcíny, které poskytují plodná kuřecí vejce bez speciálních patogenů (SPF), kuřata SPF a diagnostické produkty používané k výrobě vakcín. Společnost také poskytuje zákazníkům v oblasti biofarmaceutického průmyslu služby v oblasti smluvního vivariového provozu. Společnost Charles River Laboratories International, Inc. byla založena v roce 1947 a sídlí ve Wilmingtonu ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
18700
Založení
2000-06-23
Podobné společnosti
$ 43.17
- $ 0.39
$ 306.69
+ $ 1.13
$ 17.74
- $ 0.27
$ 11.44
- $ 0.11
$ 92.19
+ $ 1.41
$ 266.86
+ $ 0.67
$ 120.02
- $ 3.67
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 4,015.4 | 4,015.4 | 4,050.0 | 4,129.4 | 3,976.1 | 3,540.2 | 2,923.9 | 2,621.2 | 2,266.1 | 1,857.6 | 1,681.4 | 1,363.3 | 1,297.7 | 1,165.5 | 1,129.5 | 1,142.6 | 1,133.4 | |
| Cost of Revenues | 2,693.9 | 2,789.8 | 2,718.2 | 2,626.9 | 2,513.4 | 2,205.5 | 1,850.4 | 1,662.9 | 1,426.0 | 1,155.3 | 1,034.8 | 832.2 | 825.0 | 770.6 | 737.4 | 740.4 | 748.7 | |
| Gross Profit | 1,321.4 | 1,225.6 | 1,331.8 | 1,502.6 | 1,462.7 | 1,334.6 | 1,073.5 | 958.3 | 840.1 | 702.3 | 646.7 | 531.1 | 472.7 | 394.9 | 392.1 | 402.2 | 384.8 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 994.2 | 1,004.9 | 1,032.1 | 984.2 | 1,002.5 | 1,009.8 | 1,026.1 | 1,011.6 | 1,013.5 | 1,026.6 | |
| Cost of Revenues | 686.4 | 666.1 | 675.1 | 666.4 | 718.3 | 660.7 | 672.4 | 666.7 | 649.4 | 664.8 | |
| Gross Profit | 307.9 | 338.8 | 357.1 | 317.7 | 284.2 | 349.0 | 353.7 | 344.8 | 364.1 | 361.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 747.9 | 665.1 | 619.9 | 528.9 | 517.6 | 443.9 | 373.4 | 367.5 | 300.4 | 269.0 | 225.7 | 208.2 | 206.1 | 262.5 | |
| Depreciation & Amortization | 403.3 | 403.3 | 361.7 | 314.1 | 335.2 | 230.3 | 335.7 | 211.9 | 64.8 | 41.4 | 41.7 | 24.2 | 26.0 | 17.8 | 18.1 | 21.8 | 24.4 | |
| Total Operating Expenses | 892.6 | 717.7 | 1,104.5 | 885.3 | 811.7 | 744.8 | 640.8 | 607.2 | 508.7 | 414.8 | 409.2 | 324.6 | 295.0 | 243.5 | 226.3 | 227.9 | 286.9 | |
| Operating Income | 428.8 | 507.8 | 227.3 | 617.3 | 651.0 | 589.9 | 432.7 | 351.2 | 331.4 | 287.5 | 237.4 | 206.4 | 177.7 | 151.4 | 165.8 | 174.3 | -298.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 197.1 | 176.1 | ||
| Depreciation & Amortization | 78.3 | 85.2 | 119.5 | 120.4 | 102.1 | 88.2 | 86.1 | 85.4 | 80.5 | 78.9 | ||
| Total Operating Expenses | 187.6 | 205.0 | 256.9 | 243.1 | 451.9 | 231.6 | 202.1 | 218.9 | 231.2 | 210.3 | ||
| Operating Income | 120.2 | 133.8 | 100.1 | 74.7 | -167.7 | 117.4 | 151.7 | 126.0 | 132.9 | 151.5 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.9 | 4.9 | 8.6 | 5.2 | 0.8 | 0.7 | 0.8 | 1.5 | 0.8 | 0.7 | 1.3 | 1.0 | 1.2 | 0.7 | 0.6 | 1.4 | 1.2 | |
| Interest Expense | 107.0 | 107.0 | 126.3 | 136.7 | 59.3 | 73.9 | 86.4 | 60.9 | 63.8 | 29.8 | 27.7 | 15.1 | 12.0 | 21.0 | 33.3 | 41.2 | 34.1 | |
| Other Expense | -528.3 | -607.3 | -134.2 | -36.0 | -28.0 | -109.2 | 14.4 | -47.1 | 13.3 | 38.5 | 11.9 | 3.0 | 10.7 | 7.2 | -3.3 | -0.4 | -397.9 | |
| IBT | -99.5 | -99.5 | 93.1 | 581.3 | 623.0 | 480.7 | 447.1 | 304.1 | 281.7 | 297.0 | 222.9 | 195.4 | 177.6 | 138.3 | 129.7 | 132.7 | -334.1 | |
| Income Tax Expense | 42.7 | 42.7 | 67.8 | 100.9 | 130.4 | 81.9 | 81.8 | 50.0 | 54.5 | 171.4 | 66.8 | 43.4 | 47.7 | 32.9 | 27.6 | 17.1 | 0.0 | |
| Net Income | -144.3 | -144.3 | 10.3 | 474.6 | 486.2 | 391.0 | 364.3 | 252.0 | 226.4 | 123.4 | 154.8 | 149.3 | 126.7 | 102.8 | 97.3 | 109.6 | -336.7 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.0 | 1.4 | 1.1 | 1.4 | 1.8 | 1.5 | 3.0 | 2.2 | 1.6 | 1.4 | ||
| Interest Expense | 23.8 | 25.4 | 30.0 | 27.9 | 28.2 | 30.3 | 32.8 | 35.0 | 33.5 | 33.7 | ||
| Other Expense | -414.3 | -46.6 | -28.7 | -38.7 | -49.1 | -26.2 | -32.0 | -27.0 | 75.8 | -38.6 | ||
| IBT | -294.1 | 87.2 | 71.4 | 36.0 | -216.8 | 91.2 | 119.7 | 99.0 | 208.7 | 112.9 | ||
| Income Tax Expense | -17.8 | 31.6 | 18.7 | 10.1 | -3.0 | 20.9 | 25.4 | 24.5 | 19.8 | 24.9 | ||
| Net Income | -276.6 | 54.4 | 52.3 | 25.5 | -215.7 | 68.7 | 90.0 | 67.3 | 187.1 | 87.4 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | $2.15 | $2.03 | $2.16 | $-5.38 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | $2.12 | $2.01 | $2.14 | $-5.38 | |
| Shares Outstanding | 49.2 | 49.6 | 51.4 | 51.2 | 50.8 | 50.3 | 49.6 | 48.7 | 47.9 | 47.5 | 47.0 | 46.5 | 46.6 | 47.7 | 47.9 | 50.8 | 62.6 | |
| Diluted Shares Outstanding | 49.2 | 49.6 | 51.6 | 51.5 | 51.3 | 51.4 | 50.6 | 49.7 | 49.0 | 48.6 | 48.0 | 47.6 | 47.6 | 48.5 | 48.4 | 51.3 | 62.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.65 | $1.70 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.62 | $1.69 | ||
| Shares Outstanding | 49.2 | 49.2 | 49.1 | 50.7 | 51.1 | 51.4 | 51.6 | 51.4 | 51.3 | 51.3 | ||
| Diluted Shares Outstanding | 49.2 | 49.4 | 49.3 | 50.9 | 51.1 | 51.6 | 51.8 | 51.8 | 51.6 | 51.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 179.5 | 194.6 | 276.8 | 233.9 | 241.2 | 228.4 | 238.0 | 195.4 | 163.8 | 117.6 | 117.9 | 160.0 | 155.9 | 109.7 | 68.9 | 179.2 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 1.0 | 0.9 | 0.9 | 28.5 | 3.8 | 20.5 | 16.2 | 11.2 | 6.8 | 5.4 | 9.8 | |
| Total Cash & ST Investments | 179.5 | 194.6 | 276.8 | 233.9 | 241.2 | 228.4 | 238.0 | 195.4 | 163.8 | 117.6 | 117.9 | 160.0 | 155.9 | 109.7 | 68.9 | 179.2 | |
| Accounts Receivable | 762.2 | 720.9 | 780.4 | 752.4 | 642.9 | 617.7 | 514.0 | 472.2 | 430.0 | 364.1 | 270.1 | 258.0 | 220.6 | 203.0 | 184.8 | 193.0 | |
| Inventory | 349.1 | 278.5 | 380.3 | 255.8 | 199.1 | 185.7 | 160.7 | 127.9 | 115.0 | 95.8 | 93.7 | 89.0 | 89.4 | 88.5 | 93.0 | 100.3 | |
| Other Current Assets | 208.4 | 209.0 | 171.3 | 107.6 | 97.3 | 72.6 | 56.0 | 48.8 | 81.3 | 45.0 | 47.3 | 99.8 | 85.8 | 83.6 | 79.1 | 80.5 | |
| Total Current Assets | 1,499.3 | 1,403.1 | 1,608.7 | 1,439.0 | 1,274.1 | 1,201.1 | 1,021.3 | 897.8 | 826.6 | 656.8 | 559.2 | 606.9 | 552.6 | 485.3 | 425.8 | 552.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 207.7 | 182.8 | 229.4 | 194.6 | 210.2 | 179.2 | 327.0 | 276.8 | 157.2 | 200.4 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 207.7 | 182.8 | 229.4 | 194.6 | 210.2 | 179.2 | 327.0 | 276.8 | 157.2 | 200.4 | |
| Accounts Receivable | 734.5 | 767.6 | 756.6 | 720.9 | 754.2 | 762.2 | 787.0 | 780.4 | 799.3 | 800.6 | |
| Inventory | 302.6 | 279.6 | 290.2 | 278.5 | 336.2 | 349.1 | 361.3 | 380.3 | 293.0 | 285.3 | |
| Other Current Assets | 287.4 | 239.9 | 230.2 | 209.0 | 194.1 | 208.7 | 192.9 | 171.3 | 194.9 | 218.4 | |
| Total Current Assets | 1,532.1 | 1,469.9 | 1,506.4 | 1,403.1 | 1,494.7 | 1,499.3 | 1,668.2 | 1,608.7 | 1,444.3 | 1,504.8 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2,000.0 | 2,016.5 | 2,033.8 | 1,857.4 | 1,584.0 | 1,302.6 | 1,184.2 | 932.9 | 782.0 | 755.8 | 678.0 | 676.8 | 676.2 | 717.0 | 738.0 | 752.7 | |
| Goodwill | 3,079.7 | 2,846.6 | 3,095.0 | 2,849.9 | 2,711.9 | 1,809.2 | 1,540.6 | 1,247.1 | 804.9 | 787.5 | 438.8 | 321.1 | 230.7 | 208.6 | 197.6 | 198.4 | |
| Intangible Assets | 800.1 | 723.4 | 864.1 | 955.3 | 1,061.2 | 787.6 | 689.4 | 610.9 | 369.8 | 394.4 | 280.8 | 178.9 | 84.5 | 84.9 | 93.4 | 121.2 | |
| Long-Term Investments | 233.3 | 218.4 | 243.8 | 311.6 | 201.4 | 221.8 | 123.0 | 88.6 | 71.1 | 45.3 | 32.7 | 27.0 | 17.9 | 8.5 | 0.0 | 0.0 | |
| Other Long-Term Assets | 299.7 | 278.2 | 309.4 | 148.3 | 151.5 | 130.8 | 89.6 | 55.2 | 52.9 | 43.1 | 38.9 | 51.3 | 47.2 | 43.5 | 58.6 | 63.1 | |
| Total Long-Term Assets | 6,449.0 | 6,125.3 | 6,586.3 | 6,163.7 | 5,750.2 | 4,289.7 | 3,671.5 | 2,958.0 | 2,103.3 | 2,055.0 | 1,509.3 | 1,278.3 | 1,092.1 | 1,101.1 | 1,132.5 | 1,180.5 | |
| Total Assets | 7,948.3 | 7,528.3 | 8,195.0 | 7,602.8 | 7,024.3 | 5,490.8 | 4,692.8 | 3,855.9 | 2,929.9 | 2,711.8 | 2,068.5 | 1,885.2 | 1,644.6 | 1,586.3 | 1,558.3 | 1,733.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1,965.9 | 1,992.5 | 1,990.0 | 2,016.5 | 2,025.1 | 2,000.0 | 2,003.1 | 2,033.8 | 1,900.8 | 1,926.8 | |
| Goodwill | 2,922.3 | 2,936.3 | 2,873.4 | 2,846.6 | 3,124.6 | 3,079.7 | 3,070.2 | 3,095.0 | 2,884.6 | 2,916.6 | |
| Intangible Assets | 571.1 | 602.5 | 655.7 | 723.4 | 778.5 | 800.1 | 827.6 | 864.1 | 886.3 | 929.9 | |
| Long-Term Investments | 196.2 | 216.1 | 214.0 | 218.4 | 236.0 | 231.9 | 243.5 | 243.8 | 301.8 | 300.3 | |
| Other Long-Term Assets | 289.3 | 296.5 | 294.1 | 278.2 | 307.0 | 301.2 | 303.1 | 309.4 | 154.9 | 155.5 | |
| Total Long-Term Assets | 5,981.7 | 6,090.7 | 6,076.0 | 6,125.3 | 6,509.1 | 6,449.0 | 6,484.6 | 6,586.3 | 6,162.7 | 6,267.6 | |
| Total Assets | 7,513.8 | 7,560.5 | 7,582.4 | 7,528.3 | 8,003.8 | 7,948.3 | 8,152.8 | 8,195.0 | 7,607.0 | 7,772.4 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 133.1 | 140.3 | 168.9 | 205.9 | 198.1 | 122.5 | 111.5 | 66.3 | 77.8 | 68.5 | 36.7 | 33.8 | 31.8 | 31.2 | 34.3 | 30.6 | |
| Short-Term Debt | 3.2 | 0.0 | 0.0 | 0.0 | 2.8 | 50.2 | 38.5 | 31.4 | 31.0 | 27.3 | 17.0 | 31.9 | 21.4 | 139.4 | 14.8 | 30.6 | |
| Other Current Liabilities | 564.0 | 605.4 | 605.5 | 621.4 | 612.6 | 459.1 | 388.3 | 315.4 | 237.1 | 206.1 | 176.7 | 152.3 | 139.7 | 115.2 | 111.2 | 131.7 | |
| Current Liabilities | 947.5 | 994.1 | 1,055.1 | 1,091.6 | 1,033.2 | 839.8 | 710.2 | 558.2 | 463.5 | 429.6 | 311.8 | 296.2 | 247.0 | 342.2 | 216.8 | 259.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 169.6 | 145.8 | 149.3 | 140.3 | 136.0 | 133.1 | 129.7 | 168.9 | 136.3 | 140.2 | |
| Short-Term Debt | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.7 | 3.7 | |
| Other Current Liabilities | 711.9 | 666.3 | 651.3 | 605.4 | 624.3 | 567.2 | 568.7 | 605.5 | 561.3 | 564.0 | |
| Current Liabilities | 1,121.9 | 1,080.4 | 1,051.1 | 994.1 | 1,012.2 | 947.5 | 954.8 | 1,055.1 | 993.8 | 1,007.6 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 2,382.5 | 2,724.0 | 3,485.6 | 3,097.3 | 2,916.5 | 2,085.2 | 1,965.9 | 1,636.6 | 1,114.1 | 1,207.7 | 846.0 | 746.0 | 642.4 | 527.1 | 703.2 | 670.3 | |
| Capital Leases | 455.4 | 483.8 | 419.2 | 389.7 | 253.0 | 155.6 | 116.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 703.2 | 0.0 | |
| Def. Tax Liability | 165.2 | 107.0 | 191.3 | 215.6 | 239.7 | 217.0 | 167.3 | 143.6 | 89.5 | 55.7 | 48.2 | 30.8 | 15.0 | 13.1 | 0.0 | 0.0 | |
| Total Liabilities | 4,175.2 | 4,020.3 | 4,536.0 | 4,579.3 | 4,432.3 | 3,347.2 | 3,026.3 | 2,517.6 | 1,865.9 | 1,858.0 | 1,302.9 | 1,180.8 | 980.0 | 983.1 | 1,029.2 | 1,044.6 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 2,628.6 | 2,786.0 | 2,985.9 | 2,724.0 | 2,759.5 | 2,838.0 | 3,078.5 | 3,485.6 | 3,295.1 | 3,481.7 | |
| Capital Leases | 0.0 | 453.7 | 475.1 | 483.8 | 432.8 | 428.6 | 418.1 | 419.2 | 390.4 | 401.6 | |
| Def. Tax Liability | 123.0 | 109.3 | 107.3 | 107.0 | 167.7 | 165.2 | 180.1 | 191.3 | 185.3 | 207.4 | |
| Total Liabilities | 4,063.0 | 4,161.0 | 4,340.6 | 4,020.3 | 4,176.1 | 4,175.2 | 4,448.9 | 4,536.0 | 4,256.3 | 4,472.4 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | |
| Retained Earnings | 2,053.6 | 1,812.1 | 1,887.2 | 1,432.9 | 980.8 | 625.4 | 280.3 | 42.1 | 288.7 | 165.3 | 10.5 | -138.8 | -265.5 | -368.3 | -465.6 | -575.2 | |
| Comprehensive Income | -269.7 | -317.3 | -196.4 | -262.1 | -164.7 | -138.9 | -178.0 | -172.7 | -144.7 | -253.8 | -135.5 | -74.2 | 5.4 | 6.6 | 4.6 | 33.6 | |
| Total Common Equity | 3,722.7 | 3,461.5 | 3,596.9 | 2,976.3 | 2,534.8 | 2,114.6 | 1,634.6 | 1,317.3 | 1,045.1 | 836.8 | 733.1 | 672.2 | 641.0 | 600.8 | 527.4 | 687.4 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Retained Earnings | 1,944.3 | 1,889.9 | 1,837.6 | 1,812.1 | 2,122.8 | 2,053.6 | 1,959.8 | 1,887.2 | 1,720.4 | 1,633.1 | |
| Comprehensive Income | -191.6 | -166.5 | -265.2 | -317.3 | -192.9 | -269.7 | -249.9 | -196.4 | -268.1 | -208.3 | |
| Total Common Equity | 3,405.4 | 3,353.3 | 3,194.3 | 3,461.5 | 3,782.3 | 3,722.7 | 3,640.4 | 3,596.9 | 3,306.0 | 3,251.7 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 2,841.2 | 2,724.0 | 3,066.4 | 3,097.3 | 2,919.3 | 2,135.4 | 2,004.5 | 1,668.0 | 1,145.1 | 1,235.0 | 863.0 | 777.9 | 663.8 | 666.5 | 717.9 | 700.9 | |
| Book Value | 3,773.1 | 3,508.1 | 3,659.0 | 3,023.5 | 2,592.0 | 2,143.7 | 1,666.5 | 1,338.3 | 1,064.0 | 853.8 | 765.6 | 704.3 | 664.7 | 603.2 | 529.1 | 688.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 45.4 | 46.3 | 47.4 | 46.6 | 45.4 | 50.4 | 63.5 | 62.1 | 44.7 | 48.3 | |
| Book Value | 3,405.4 | 3,353.3 | 3,194.3 | 3,461.5 | 3,782.3 | 3,722.7 | 3,640.4 | 3,596.9 | 3,306.0 | 3,251.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 439.9 | -142.2 | 25.3 | 480.4 | 492.6 | 398.8 | 365.3 | 254.1 | 227.2 | 125.6 | 156.1 | 152.0 | 129.9 | 105.4 | 102.1 | 115.5 | -334.1 | |
| Depreciation & Amortization | 330.8 | 403.3 | 361.7 | 314.1 | 303.9 | 265.5 | 234.9 | 198.1 | 161.8 | 131.2 | 126.7 | 94.9 | 96.4 | 96.6 | 81.3 | 85.2 | 93.6 | |
| Stock-Based Compensation | 75.6 | 71.1 | 69.9 | 72.0 | 73.6 | 71.5 | 56.3 | 57.3 | 47.3 | 44.0 | 43.6 | 40.1 | 31.0 | 24.5 | 21.9 | 21.7 | 25.5 | |
| Change Working Capital | -18.7 | 14.1 | -30.3 | -102.4 | -152.6 | 42.9 | -26.3 | 6.2 | 14.8 | 5.9 | -30.0 | 9.6 | -3.8 | -25.4 | -26.0 | -27.0 | 7.6 | |
| Change In Accounts Receivable | 15.9 | 35.7 | 21.6 | -33.4 | -150.6 | -26.6 | -85.6 | -8.3 | -21.2 | -48.3 | -52.8 | -17.0 | -28.1 | -19.5 | -16.3 | 7.7 | -5.6 | |
| Change In Accounts Payable | -1.9 | 2.9 | -14.3 | -20.4 | -2.7 | 44.9 | 0.7 | 29.8 | -12.7 | 0.0 | 22.1 | 1.2 | 4.6 | -7.1 | -3.3 | 2.2 | 0.1 | |
| Change In Inventories | -19.9 | -48.8 | 16.8 | -62.3 | -78.5 | -25.2 | -18.4 | -21.4 | -13.3 | -17.8 | -4.0 | 3.4 | -3.0 | -1.6 | 0.8 | 3.8 | 2.0 | |
| Other Non-cash Items | 341.4 | 466.6 | 375.4 | -29.4 | -62.0 | 6.0 | -83.6 | -12.8 | -0.3 | -18.7 | 0.0 | -13.0 | -9.6 | 6.7 | 27.4 | 18.5 | 418.7 | |
| Cash from Operations | 749.8 | 0.0 | 0.0 | 683.9 | 619.6 | 760.8 | 546.6 | 480.9 | 441.1 | 316.3 | 298.3 | 286.4 | 251.1 | 207.1 | 207.9 | 205.3 | 169.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -276.6 | 55.6 | 52.7 | 25.9 | -213.7 | 70.3 | 94.3 | 74.5 | 189.0 | 88.0 | |
| Depreciation & Amortization | 78.3 | 85.2 | 119.5 | 120.4 | 102.1 | 88.2 | 86.1 | 85.4 | 80.5 | 78.9 | |
| Stock-Based Compensation | 0.0 | 23.3 | 17.0 | 13.1 | 17.2 | 19.3 | 16.6 | 16.7 | 19.5 | 22.8 | |
| Change Working Capital | 6.8 | -5.1 | 11.2 | 1.3 | -42.4 | 71.5 | -11.3 | -48.1 | 38.4 | 2.3 | |
| Change In Accounts Receivable | 27.6 | 26.6 | 10.9 | -29.4 | 3.3 | 17.2 | 18.4 | -17.3 | 25.6 | -10.8 | |
| Change In Accounts Payable | -37.9 | 24.5 | -9.0 | 25.3 | -7.2 | -0.7 | 2.1 | -8.5 | 6.1 | -1.5 | |
| Change In Inventories | -3.5 | -31.3 | 7.9 | -21.9 | 3.0 | 4.0 | 4.2 | 5.6 | -18.2 | -11.5 | |
| Other Non-cash Items | 399.2 | 29.1 | 26.2 | 30.1 | 337.6 | 15.4 | 20.0 | 2.4 | -83.8 | 25.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 220.9 | 205.5 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -262.9 | -219.2 | -233.0 | -318.5 | -324.7 | -228.8 | -166.6 | -140.5 | -140.1 | -82.4 | -55.3 | -63.3 | -56.9 | -39.2 | -47.5 | -49.1 | -42.9 | |
| Acquisitions | -84.2 | 0.0 | -5.5 | -194.8 | -120.1 | -1,170.4 | -418.6 | -515.7 | -824.9 | 47.5 | -648.5 | -247.7 | -234.3 | -29.2 | -16.9 | 0.0 | 2.8 | |
| Investments | -67.1 | -20.1 | -52.9 | -54.2 | -158.3 | -45.6 | -26.7 | -22.3 | -25.1 | -46.2 | -40.2 | -34.2 | -26.6 | -17.6 | -18.5 | -24.6 | -27.6 | |
| Sales of Investment | 16.1 | 9.1 | 41.7 | 6.7 | 4.5 | 6.5 | 11.4 | 0.9 | 35.8 | 9.1 | 54.0 | 27.1 | 21.0 | 11.6 | 25.2 | 31.6 | 72.5 | |
| Other Investing Activities | -67.6 | 0.0 | 0.0 | -2.3 | -9.3 | 0.3 | -1.1 | -3.9 | -0.8 | -0.5 | 3.7 | -2.2 | -1.2 | 0.3 | 2.8 | 5.4 | 1.0 | |
| Cash from Investing | -465.6 | 0.0 | 0.0 | -563.2 | -607.9 | -1,437.9 | -601.5 | -681.5 | -955.0 | -72.6 | -686.4 | -320.3 | -298.0 | -74.0 | -55.0 | -36.6 | 5.8 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -89.0 | -35.6 | -35.3 | -59.3 | -75.6 | -38.7 | -39.5 | -79.1 | -78.3 | -65.9 | |
| Acquisitions | 19.1 | -17.4 | 0.0 | 17.4 | 0.0 | 0.0 | -5.5 | 0.0 | -144.6 | 65.9 | |
| Investments | -7.5 | -4.5 | -2.8 | -5.3 | -7.6 | -9.7 | -21.7 | -13.9 | -17.9 | -13.6 | |
| Sales of Investment | 3.5 | 3.5 | 0.5 | 1.6 | 2.2 | 27.1 | 4.9 | 7.5 | 2.7 | 1.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -66.9 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -238.4 | -79.6 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -797.6 | 0.0 | 0.0 | -75.3 | -2,932.6 | -6,242.9 | -2,200.4 | -3,124.6 | -2,201.0 | -372.4 | -656.6 | -417.3 | -194.5 | -523.3 | -140.3 | -253.0 | -381.5 | |
| Debt Issued | 558.7 | 2,724.0 | -342.4 | 44.4 | 3,110.6 | 7,026.8 | 2,331.3 | 3,461.0 | 2,723.9 | 282.5 | 1,028.6 | 502.5 | 308.6 | 520.6 | 88.9 | 270.1 | 1,082.4 | |
| Issuance of Common Stock | 32.2 | 0.0 | 0.0 | 0.0 | 25.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -18.4 | -360.7 | -119.2 | -24.2 | -38.7 | -40.7 | -24.0 | -18.1 | -13.8 | -106.9 | -12.3 | -117.5 | -122.0 | -165.9 | -64.2 | -283.8 | -356.5 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 470.1 | 0.0 | 0.0 | 14.0 | 2,903.8 | 6,956.2 | 2,271.6 | 3,374.6 | 2,772.9 | 270.9 | 1,059.6 | 539.4 | 378.0 | 605.0 | 93.4 | 265.0 | 570.2 | |
| Cash from Financing | -306.8 | 0.0 | 0.0 | -85.5 | -42.4 | 672.6 | 47.2 | 231.9 | 558.1 | -208.5 | 390.7 | 4.5 | 61.4 | -84.2 | -111.1 | -271.8 | -167.9 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 122.6 | -162.6 | |
| Debt Issued | 2,631.3 | -154.8 | -199.8 | 261.9 | -35.5 | -78.5 | -240.5 | 12.1 | 284.3 | -12.8 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.1 | -0.1 | -7.4 | -353.1 | -0.1 | -100.8 | -8.9 | -9.4 | -0.1 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.8 | -0.2 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 123.6 | -162.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -27.3 | 10.4 | -78.9 | 43.3 | -5.1 | 13.2 | -6.9 | 42.7 | 31.0 | 46.4 | -0.3 | -42.1 | 4.1 | 46.2 | 40.8 | -110.3 | -3.4 | |
| Closing Cash Balance | 179.5 | 216.0 | 205.6 | 284.5 | 241.2 | 246.3 | 233.1 | 240.0 | 197.3 | 166.3 | 117.6 | 117.9 | 160.0 | 155.9 | 109.7 | 68.9 | 179.2 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 6.8 | 24.5 | -47.0 | 26.2 | -6.1 | 30.6 | -157.8 | 54.1 | 118.9 | -43.2 | |
| Closing Cash Balance | 214.4 | 209.2 | 184.7 | 231.7 | 205.6 | 211.6 | 179.5 | 337.4 | 284.5 | 165.6 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 486.9 | 518.5 | 501.6 | 365.4 | 294.9 | 532.0 | 380.0 | 340.4 | 301.1 | 233.8 | 243.0 | 223.1 | 194.1 | 168.0 | 160.4 | 156.1 | 126.2 | |
| Real Free Cash Flow | 411.3 | 447.4 | 431.7 | 293.3 | 221.3 | 460.6 | 323.7 | 283.2 | 253.7 | 189.8 | 199.4 | 183.0 | 163.1 | 143.4 | 138.5 | 134.4 | 100.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 58.6 | 178.2 | 169.3 | 112.4 | 83.7 | 213.1 | 154.0 | 50.7 | 142.6 | 139.5 | |
| Real Free Cash Flow | 58.6 | 155.0 | 152.3 | 99.2 | 66.5 | 193.7 | 137.5 | 34.0 | 123.1 | 116.7 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -52.4 | 32.5 | 63 |
| P/S | 1.9 | 2.8 | 57.8 |
| P/B | 2.2 | 4.2 | 29.8 |
| P/FCF | 16.3 | 27.4 | 549.4 |
| Market cap | $8.3 | $8.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 40.7 % | 0 % |
| Debt to Income | -1823 % | 895.7 % | 0 % |
| Debt to Free cash flow | 565.8 % | 11.8 % | 0 % |
| Interest expense percentage | 25 % | 17.2 % | 2.9 % |
| Current ratio | 1.4 | 1.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -4.2 % | 10 % | 0 % |
| ROA | -1.9 % | 3.7 % | 0 % |
| CapEx to Revenue | 5.5 % | 5.1 % | 0 % |
| RaD to Revenue | 0 % | 0 % | 0 % |
| ROEM | 199,770.2 | 136956.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 32.9 % | 36 % | 47.8 % |
| Operating margin | 10.7 % | 11.5 % | 28 % |
| Net margin | -3.6 % | 6.4 % | 19.8 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 49.2 mil | 50.5 mil |
| Employee count | 20.1 tis | 10.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
